Estrogen receptors play a crucial role in regulating lipid accumulation and improving insulin sensitivity and are therefore regarded as therapeutic targets for preventing obesity and metabolic disorders [57]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.